Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1465766017 | Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 1485588012 | Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Combination ulcer healing drugs | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Product containing clarithromycin | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Product containing metronidazole | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Is a | Product containing lansoprazole | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Lansoprazole | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Clarithromycin | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Has active ingredient | Metronidazole | false | Inferred relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Availability | Available only as a proprietary | false | Additional relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | NHS prescribing status | NHS prescribable | false | Additional relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Legal category | Prescription Only Medicine | false | Additional relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | CSM recommendation to report adverse reactions | Report only serious adverse reactions to the Committee on Safety of Medicines | false | Additional relationship | Existential restriction modifier | ||
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack | Product name type | Generic name | false | Additional relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR